UK markets open in 3 hours 11 minutes
NIKKEI 225
38,303.39 -531.71 (-1.37%) HANG SENG
18,442.60 -36.77 (-0.20%) CRUDE OIL
78.18 -0.20 (-0.26%) GOLD FUTURES
2,324.70 +0.50 (+0.02%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,387.80 -230.62 (-0.46%)
Bio-Techne Corporation (TECH)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 12.21B |
| Enterprise value | 12.56B |
| Trailing P/E | 61.97 |
| Forward P/E | 36.76 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 10.81 |
| Price/book (mrq) | 6.06 |
| Enterprise value/revenue | 10.88 |
| Enterprise value/EBITDA | 34.55 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.22 |
| 52-week change 3 | -4.61% |
| S&P500 52-week change 3 | 25.38% |
| 52-week high 3 | 89.91 |
| 52-week low 3 | 51.79 |
| 50-day moving average 3 | 69.99 |
| 200-day moving average 3 | 70.74 |
Share statistics
| Avg vol (3-month) 3 | 1.12M |
| Avg vol (10-day) 3 | 1.48M |
| Shares outstanding 5 | 157.58M |
| Implied shares outstanding 6 | 159.73M |
| Float 8 | 155.51M |
| % held by insiders 1 | 0.97% |
| % held by institutions 1 | 101.12% |
| Shares short (15 Apr 2024) 4 | 5.75M |
| Short ratio (15 Apr 2024) 4 | 5.68 |
| Short % of float (15 Apr 2024) 4 | 4.76% |
| Short % of shares outstanding (15 Apr 2024) 4 | 3.66% |
| Shares short (prior month 15 Mar 2024) 4 | 5.1M |
Dividends & splits
| Forward annual dividend rate 4 | 0.32 |
| Forward annual dividend yield 4 | 0.41% |
| Trailing annual dividend rate 3 | 0.32 |
| Trailing annual dividend yield 3 | 0.42% |
| 5-year average dividend yield 4 | 0.44 |
| Payout ratio 4 | 25.60% |
| Dividend date 3 | 24 May 2024 |
| Ex-dividend date 4 | 10 May 2024 |
| Last split factor 2 | 4:1 |
| Last split date 3 | 30 Nov 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 17.59% |
| Operating margin (ttm) | 22.14% |
Management effectiveness
| Return on assets (ttm) | 5.58% |
| Return on equity (ttm) | 10.40% |
Income statement
| Revenue (ttm) | 1.15B |
| Revenue per share (ttm) | 7.32 |
| Quarterly revenue growth (yoy) | 3.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 303.98M |
| Net income avi to common (ttm) | 202.93M |
| Diluted EPS (ttm) | 1.25 |
| Quarterly earnings growth (yoy) | -30.10% |
Balance sheet
| Total cash (mrq) | 145.31M |
| Total cash per share (mrq) | 0.92 |
| Total debt (mrq) | 494.73M |
| Total debt/equity (mrq) | 24.56% |
| Current ratio (mrq) | 4.08 |
| Book value per share (mrq) | 12.81 |
Cash flow statement
| Operating cash flow (ttm) | 306.88M |
| Levered free cash flow (ttm) | 178.66M |
© 2024 Yahoo. All rights reserved.